Description
Recombinant monoclonal antibody to CD30. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma YMSM636. This chimeric human antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques.
Target
CD30
Target Alias Names
TNFRSF8, YMSM 636.4.10, YMSM636, Tumor necrosis factor receptor superfamily member 8, CD30L receptor, Lymphocyte activation antigen CD30, Tnfrsf8
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression